Proteasome Activity Not M-Protein Production Influences Multiple Myeloma (MM) Responsiveness to Bortezomib (BZB): The Key Role of PSMB5

被引：0
|
作者：
Zhou, Ping [1 ]
Ma, Xun [1 ]
Comenzo, Raymond L. [1 ]
机构：
[1] Tufts Med Ctr, Boston, MA USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1489 / 1490
页数：2
相关论文
共 4 条
  • [1] Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma
    Allmeroth, Kira
    Horn, Moritz
    Kroef, Virginia
    Miethe, Stephan
    Mueller, Roman-Ulrich
    Denzel, Martin S.
    LEUKEMIA, 2021, 35 (03) : 887 - 892
  • [2] Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma
    Kira Allmeroth
    Moritz Horn
    Virginia Kroef
    Stephan Miethe
    Roman-Ulrich Müller
    Martin S. Denzel
    Leukemia, 2021, 35 : 887 - 892
  • [3] Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation
    Jin, Shuhan
    Li, Bo
    Zhang, Bibo
    Gao, Xuejie
    Jia, Xinyan
    Xu, Li
    Chang, Shuaikang
    Hu, Ke
    Wang, Guanli
    Xu, Zhijian
    Zhang, Ting
    Song, Dongliang
    Yang, Guang
    Wu, Xiaosong
    Zhu, Huabin
    Huang, Cheng
    Lu, Yumeng
    Shi, Jumei
    Zhu, Weiliang
    Chen, Gege
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 55 (12) : 1884 - 1891
  • [4] Proteasome Activity As a Biomarker in Multiple Myeloma (MM): In MM Cells Treated with Bortezomib (BTZ) or Epoxomicin (EPX) Caspase 3/7 Activation Is Inversely Related to Baseline β1 and β5 Activity
    Zhou, Ping
    Ma, Xun
    Comenzo, Raymond L.
    BLOOD, 2011, 118 (21) : 621 - 622
1